Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG vs Lactulose for Overt Hepatic Encephalopathy
NCT03100513Phase 4Unknown
- Start
- Mar 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 3350 + bisacodyl in hepatic encephalopathy (HE). Status: unknown.
02
Drugs
polyethylene glycol 3350 + bisacodyl
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03100513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03100513.